<it>KRAS </it>rs61764370 is associated with HER2-overexpressed and poorly-differentiated breast cancer in hormone replacement therapy users: a case control study
<p>Abstract</p> <p>Background</p> <p>A single nucleotide polymorphism located in the 3'-untranslated region of the <it>KRAS </it>oncogene (<it>KRAS </it>variant; rs61764370) disrupts a let-7 miRNA binding and was recently reported to act as...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-03-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2407/12/105 |